School of Medicine
Showing 1-10 of 28 Results
-
Kiera Davis
Clinical Associate Director, Education & Training, Med/Stanford Center for Clinical Research
Current Role at StanfordClinical Associate Director, Education & Training
Program Lead, SHC Tri-Valley Program Management Office (PMO) -
Walter De Brouwer
Adjunct Professor, Primary Care and Population Health
BioWalter A. De Brouwer, Ph.D., is an Adjunct Professor at the Stanford School of Medicine. As a core faculty member at CERC DICE, he is the course director for “Innovation in Healthcare: from idea to incorporation,” which includes a bi-weekly presentation. He also serves on the advisory committee focused on the strategic direction for the program and is part of the leadership team developing the program curriculum and practicum. He is the founder of doc.ai, a Palo-Alto-based Federated Edge Learning company for the payers/pharma industry which merged in January 2020 with Sharecare Inc.
Professional Education
Bachelor’s degree in Philology (University of Ghent, Belgium)
Master’s degree in Formal Linguistics (University of Ghent, Belgium)
Post-graduate: Epistemology (University of Ghent, Belgium)
Ph.D. Computational Semiotics (Catholic University of Tilburg, the Netherlands). -
Colette DeJong
Clinical Instructor (Affiliated), Medicine - Med/Cardiovascular Medicine
Staff, Medicine - Med/Stanford Prevention Research CenterBioDr. Colette DeJong is general cardiologist and health services researcher at the VA Palo Alto. A graduate of Brown University and the University of California, San Francisco School of Medicine, Dr. DeJong completed an internal medicine residency, chief residency, and fellowship in cardiovascular medicine at UCSF, as well as a two-year editorial fellowship at JAMA Internal Medicine and a research fellowship at the UCSF Center for Healthcare Value. Dr. DeJong’s research focuses on improving access to effective cardiovascular therapies. She is interested in developing and evaluating novel strategies to improve care delivery, such as cardiovascular combination pills (“polypills”). Dr. DeJong served as the principal investigator of a pilot clinical trial of heart failure polypills at Zuckerberg San Francisco General Hospital.
